Basic Information:
Symbol | MOSPD2 |
Protein Name | Motile sperm domain-containing protein 2 |
Species | Human |
Entrez ID | 158747 |
Uniprot ID | Q8NHP6 |
Membrane Contact Site |
ER-Endosome; Endosome-ER
|
Location (from literature) | ER |
Cell line/Tissue | HeLa cells; HEK293T cells |
Experimental Method | Low throughput experimental methods |
Protein Sequence | |
More related results |
Complex Information:
Complex ID | Subunit of complex | Subcellular location | Species | More |
CMCS00013 | MOSPD2; STARD3NL | ER-Endosome; Endosome-ER | Human | more | CMCS00014 | MOSPD2; STARD3 | ER-Endosome; Endosome-ER | Human | more | CMCS00015 | MOSPD2; OSBPL1A | ER-Endosome; Endosome-ER | Human | more | CMCS00072 | MOSPD2; CERT1 | ER-Endosome; Endosome-ER | Human | more |
Expression Overview of MOSPD2:
Homology Information of MOSPD2:
Uniprot ID | Q8NHP6 |
EggNOG | KOG1470 |
HOGENOM | CLU_028924_1_0_1 |
OrthoDB | 2168468at2759 |
TreeFam | TF351054 |
GeneTree | ENSGT00390000016713 |
References:
Pubmed ID | 29858488 |
DOI | 10.15252/embr.201745453 |
Description | Consequently, MOSPD2 and these organelle‐bound proteins mediate the formation of contact sites between the ER and endosomes, mitochondria, or Golgi.; ll these proteins, by binding VAP proteins, are known to build contact sites between the ER and endosomes (STARD3, STARD3NL, ORP1L), mitochondria (PTPIP51), and Golgi (STARD11). |
Description of experimental evidence | The protein was validated by immunofluorescence, colocalization analysis, SDS–PAGE, western blot, coomassie blue staining, pull‐down assays, GFP‐Trap, mass spectrometry analysis, electron microscopy and immunoprecipitation in HeLa cells and HEK293T cells. |
More related results |
Pubmed ID | 33124732 |
DOI | 10.15252/embj.2019104369 |
Description | The endoplasmic reticulum possesses three major receptors, VAP‐A, VAP‐B, and MOSPD2, which interact with proteins at the surface of other organelles to build contacts; onventional FFATs (illustrated here with STARD11/CERT) which allow the formation of a stable complex between VAPs/MOSPD2 and thus the formation of MCSs. |
Description of experimental evidence | The protein was validated by pull‐down assays, immunoprecipitation,SDS–PAGE, western blot, CIP treatment, coomassie blue staining, mass spectrometry analysis, immunofluorescence and colocalization analysis in HeLa cells. |
More related results |